| Literature DB >> 35204112 |
Chongsheng Liang1, Siddabasave Gowda B Gowda2,3, Divyavani Gowda2, Toshihiro Sakurai2, Iku Sazaki1, Hitoshi Chiba4, Shu-Ping Hui1.
Abstract
Lipid hydroperoxides (LOOH) are the initial products of the peroxidation of unsaturated lipids and play a crucial role in lipid oxidation due to their ability to decompose into free radicals and cause adverse effects on human health. Thus, LOOHs are commonly considered biomarkers of oxidative stress-associated pathological conditions. Despite their importance, the sensitive and selective analytical method for determination is limited, due to their low abundance, poor stability, and low ionizing efficiency. To overcome these limitations, in this study, we chemically synthesized eight fatty acid hydroperoxides (FAOOH), including FA 18:1-OOH, FA 18:2-OOH, FA 18:3-OOH, FA 20:4-OOH, FA 20:5-OOH, FA 22:1-OOH, FA 22:6-OOH as analytes, and FA 19:1-OOH as internal standard. Then, they were chemically labeled with 2-methoxypropene (2-MxP) to obtain FAOOMxP by one-step derivatization (for 10 min). A selected reaction monitoring assisted targeted analytical method was developed using liquid chromatography/tandem mass spectrometry (LC-MS/MS). The MxP-labelling improved the stability and enhanced the ionization efficiency in positive mode. Application of reverse-phase chromatography allowed coelution of analytes and internal standards with a short analysis time of 6 min. The limit of detection and quantification for FAOOH ranged from 0.1-1 pmol/µL and 1-2.5 pmol/µL, respectively. The method was applied to profile total FAOOHs in chemically oxidized human serum samples (n = 5) and their fractions of low and high-density lipoproteins (n = 4). The linoleic acid hydroperoxide (FA 18:2-OOH) and oleic acid hydroperoxide (FA 18:1-OOH) were the most abundant FAOOHs in human serum and lipoproteins. Overall, our validated LC-MS/MS methodology features enhanced detection and rapid separation that enables facile quantitation of multiple FAOOHs, therefore providing a valuable tool for determining the level of lipid peroxidation with potential diagnostic applications.Entities:
Keywords: 2-methoxypropene; chemical derivatization; human serum; lipid hydroperoxide; lipoprotein oxidation; liquid chromatography; mass spectrometry; unsaturated fatty acids
Year: 2022 PMID: 35204112 PMCID: PMC8868426 DOI: 10.3390/antiox11020229
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Synthesis of fatty acid hydroperoxides and their 2-MxP derivatives (A) Schematic representation of the synthesis of FAOOH and FAOOMxP. (B) Chemical structure of unsaturated fatty acids used in the study.
Optimized SRM parameters for 2-methoxyprepene derivatized fatty acid hydroperoxides (FA: Fatty acid; MxP: 2-methoxypropene).
| Lipids | Parent Ion [M + Na]+ ( | Product Ion ( | Collision Energy (V) | Tube Lens (V) |
|---|---|---|---|---|
| FA 18:3-OOMxP | 405.3 | 333.3 | 11 | 57 |
| FA 18:2-OOMxP | 407.3 | 335.3 | 13 | 57 |
| FA 18:1-OOMxP | 409.2 | 207.3 | 14 | 57 |
| FA 19:1-OOMxP (IS) | 423.4 | 221.3 | 14 | 62 |
| FA 20:5-OOMxP | 429.3 | 357.3 | 12 | 64 |
| FA 20:4-OOMxP | 431.4 | 359.4 | 13 | 64 |
| FA 22:6-OOMxP | 455.3 | 383.4 | 12 | 53 |
| FA 22:1-OOMxP | 465.4 | 263.3 | 15 | 65 |
Figure 2The 1H-NMR spectrum of FA 18:1-OOH (A) and its 2-MxP derivative FA 18:1-OOMxP (B).
Figure 3The MS/MS behavior of representative species and elution profile of 2-MxP derivatives. (A) The MS/MS spectra of mono-unsaturated (FA 22:1) and poly-unsaturated (FA 20:4) fatty acid hydroperoxides (a,c) and their 2-MxP derivatives (b,d). (B) Extracted ion chromatograms of FAOOMxP standards (in plasma matrix).
Determination of linearity, LOD, and LOQ of FAOOH standards (# LOD: limit of detection, $ LOQ: limit of quantification).
| Lipids | Linearity | R2 | Range | LOD | LOQ |
|---|---|---|---|---|---|
| FA 18:3-OOH | 0.0003x + 0.0386 | 0.965 | 2.5–100 | 1 | 2.5 |
| FA 18:2-OOH | 0.0022x + 0.0141 | 0.998 | 2.5–100 | 1 | 2.5 |
| FA 18:1-OOH | 0.0026x + 0.2529 | 0.987 | 1–100 | 0.1 | 1 |
| FA 20:5-OOH | 0.0021x + 0.1837 | 0.979 | 2.5–100 | 1 | 2.5 |
| FA 20:4-OOH | 0.0017x + 0.018 | 0.988 | 2.5–100 | 1 | 2.5 |
| FA 22:6-OOH | 0.0008x − 0.003 | 0.994 | 1–100 | 0.1 | 1 |
| FA 22:1-OOH | 0.0022x + 0.0868 | 0.990 | 1–100 | 0.1 | 1 |
Recovery and reproducibility of FAOOH standards in plasma matrix (CV: coefficient of variance) # The value corresponds to the variance among FAOOH standards derivatized and injected directly without matrix.
| Lipids | Recovery (%) | Standard (CV%) # | Intra-Day (CV%) | Inter-Day (CV%) |
|---|---|---|---|---|
| FA 18:1-OOH | 69.7 ± 4.5 | 2.9 | 3.1 | 4.4 |
| FA 18:2-OOH | 53.9 ± 4.3 | 1.2 | 6.4 | 8.8 |
| FA 18:3-OOH | 54.8 ± 6.0 | 8.8 | 9.3 | 3.9 |
| FA 19:1-OOH | 70.9 ± 11.4 | 8.9 | 13.6 | 7.1 |
| FA 20:4-OOH | 48.1 ± 5.7 | 9.7 | 3.1 | 5.5 |
| FA 20:5-OOH | 50.0 ± 7.5 | 12.3 | 7.3 | 5.2 |
| FA 22:1-OOH | 76.0 ± 5.95. | 5.1 | 3.7 | 3.6 |
| FA 22:6-OOH | 49.5 ± 5.6 | 9.2 | 4.9 | 10.9 |
Figure 4Quantitation of total FAOOHs in human serum and lipoproteins. (A) Extracted ion chromatograms of standard and those detected in samples. (B) Detected FAOOHs in native and oxidized human serum (n = 5). (C) Amount of FAOOHs detected in native LDL (nLDL) and oxidized LDL (oxLDL) (n = 4). (D) Amount of FAOOHs detected in native HDL (nHDL) and oxidized HDL (oxHDL) (n = 4). Two-way ANOVA with Tukey multiple comparison tests were applied and p < 0.05 was considered to be statistically significant (ND: not detected, p= 0.0332 (*), 0.0002 (***), 0.0001 (****)).